Pa. Justices Suggest Juries Should Decide Risperdal Time Bar
Law360, Harrisburg (May 16, 2019, 7:25 PM EDT) -- In an appeal implicating thousands of pending lawsuits in Philadelphia, members of Pennsylvania’s highest court suggested on Thursday that case-by-case determinations were needed to decide whether claims over abnormal breast growth linked to the antipsychotic drug Risperdal had been brought within the statute of limitations.
Justice Max Baer appeared to credit arguments from Charles “Chip” Becker, an attorney with Kline & Specter PC representing the two men at the center of appeal, that factual disputes over when his clients should have been able to make a connection between their injuries and the Janssen Pharmaceuticals Inc. medication precluded a trial judge from deciding on...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!